Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China · Delayed Price · Currency is CNY 16.23
-0.08 (-0.49%)
Sep 11, 2026, 10:14 AM CST
SHA:601607 Revenue
Shanghai Pharmaceuticals Holding had revenue of 72.21B CNY in the quarter ending June 30, 2026, with 1.95% growth. This brings the company's revenue in the last twelve months to 289.46B, up 4.33% year-over-year. In the year 2025, Shanghai Pharmaceuticals Holding had annual revenue of 283.58B with 3.03% growth.
Revenue (ttm)
289.46B
Revenue Growth
+4.33%
P/S Ratio
0.19
Revenue / Employee
5.95M
Employees
48,640
Market Cap
54.26B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 283.58B | 8.33B | 3.03% |
| Dec 31, 2024 | 275.25B | 14.96B | 5.75% |
| Dec 31, 2023 | 260.30B | 28.31B | 12.21% |
| Dec 31, 2022 | 231.98B | 16.16B | 7.49% |
| Dec 31, 2021 | 215.82B | 23.92B | 12.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jointown Pharmaceutical Group | 167.56B |
| C.Q. Pharmaceutical Holding | 81.39B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.91B |
| China National Accord Medicines Corporation | 72.89B |
| China National Medicines Corporation | 53.56B |
| China Meheco Group | 34.97B |
| Guangxi LiuYao Group | 21.15B |
| Liaoning Cheng Da | 9.07B |
Shanghai Pharmaceuticals Holding News
- 14 days ago - Shanghai Pharmaceuticals Holding Quarterly report: H1 2026 - Filings
- 4 months ago - Shanghai Pharmaceuticals Holding Quarterly report: Q1 2026 - Filings
- 5 months ago - Shanghai Pharmaceuticals Holding Annual report: H2 2025 - Filings
- 10 months ago - Shanghai Pharmaceuticals Holding Quarterly report: Q3 2025 - Filings